U-Blot® Research Grade Anti-Human CD137/TNFRSF9/4-1BB (HOT-1030)Cat. No. WA1288Request quote
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade Anti-Human CD137/TNFRSF9/4-1BB (HOT-1030)Cat. No. WA1288
U-Blot® Research Grade Anti-Human CD137/TNFRSF9/4-1BB (EU101)Cat. No. WA1287
U-Blot® Research Grade Anti-Human CD137/TNFRSF9/4-1BB (CTX-471)Cat. No. WA1286
U-Blot® Research Grade Anti-Human CD137/TNFRSF9/4-1BB (AGEN 2373)Cat. No. WA1285
U-Blot® Research Grade Anti-Human CD137/TNFRSF9/4-1BB (ADG106)Cat. No. WA1284
U-Blot® Research Grade Anti-Human CD137/TNFRSF9/4-1BB (ADG 206)Cat. No. WA1283
U-Blot® Research Grade Anti-Human CD137/TNFRSF9/4-1BB & CD340/ERBB2/HER2 (PRS-343)Cat. No. WA1282
U-Blot® Research Grade Anti-Human CD136/MST1R Antibody (H5B14)Cat. No. WA1281
U-Blot® Research Grade Anti-Human CD136/MST1R Antibody (Aveo anti-RON)Cat. No. WA1280
U-Blot® Research Grade Anti-Human CD135/FLT3 (IMC-EB10)Cat. No. WA1279
U-Blot® Research Grade Anti-Human CD135/FLT3 (Flysyn)Cat. No. WA1278
U-Blot® Research Grade Anti-Human CD135/FLT3 (AGS62P1)Cat. No. WA1277